TOPIC

APPLE News & Analysis

3 undervalued ASX companies with sound balance sheets
Stocks
3 undervalued ASX companies with sound balance sheets
I love investing in companies that boast strong financial positions. These three cheap ASX shares could fit the bill and screen cheaply according to...
Joseph Taylor | 01 May 2025
Overpriced ASX company too successful in wrong channel
Stocks
Overpriced ASX company too successful in wrong channel
Booming online sales cannibalising more profitable in-store sales.
Johannes Faul, CFA | 30 April 2025
It is going to be a long four years: Mark’s top articles in March
Personal Finance
It is going to be a long four years: Mark’s top articles in March
Morningstar’s Director of Personal Finance was focused on volatility and tariffs in March - just like everyone else.
Mark LaMonica, CFA | 30 April 2025
More promising signs for ASX listed software player
Stocks
More promising signs for ASX listed software player
This moated small-cap looks undervalued versus our forecasts. Let alone management’s more ambitious growth targets.
Shaun Ler | 30 April 2025
Is the US headed for a recession? What analysts are saying about Q1’s GDP decline
Markets
Is the US headed for a recession? What analysts are saying about Q1’s GDP decline
The slowdown comes as US firms stock up on inventory ahead of Trump’s tariffs.
Sarah Hansen | 30 April 2025
An enlightened dividend path
Personal Finance
An enlightened dividend path
While many chase high yields, true investment power lies in companies that steadily grow dividends. This strategy, rooted in patience and discipline,...
Josh Veltman | 30 April 2025
Are you smarter than a year 12 student?
Personal Finance
Are you smarter than a year 12 student?
I recently presented a personal finance assignment given to year 12 students and here is one reader’s attempt at answering the question.
Mark LaMonica, CFA | 30 April 2025
Young & Invested: The beginner ETF portfolio
Personal Finance
Young & Invested: The beginner ETF portfolio
Diving into ETFs can often be overwhelming.
Simonelle Mody | 30 April 2025
Sim’s monthly insights for April
Personal Finance
Sim’s monthly insights for April
A break from business as usual.
Simonelle Mody | 29 April 2025
Overvalued ASX pharma play hits FDA speedbump
Stocks
Overvalued ASX pharma play hits FDA speedbump
We think a delay rather than an outright rejection for this company’s product is the likelier outcome, but the shares still look expensive.
Shane Ponraj, CFA | 29 April 2025